drugset / Trial / NCT01963793
Topical Aprepitant in Prurigo Patients
RandomizedSingle-groupQuadruple-blindTreatment
Summary
Topical Aprepitant in Prurigo Patients - An Exploratory Phase IIa Trial With Topically Applied Aprepitant in Patients With Prurigo
Timeline
- Start
- 2013-10
- Primary completion
- 2014-07
- Completion
- 2014-07
Outcome
Missed primary endpoint
registry analysis (superiority test); Aprepitant 10 mg/g Gel vs Aprepitant Gel Vehicle; p = 0.58 NCT01963793 ↗
registry Mean Difference (Final Values) -1.51 (95% CI -7.12 to 4.11) NCT01963793 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aprepitant | Other / unclassified | 10 unknown | Topical |
Indications
No indication recorded.